Relative antihypertensive and glomeruloprotective efficacies of enalapril and candesartan cilexetil in the remnant kidney model
The present studies were performed to investigate whether the differences described between the two modalities for interruption of the renin-angiotensin-aldosterone system (RAAS), angiotensin-converting enzyme inhibitors (ACE-I) and angiotensin AT 1receptor antagonists (AIIA) result in differences i...
Main Authors: | Karen A Griffin, Maria M Picken, George Bakris, Anil K Bidani |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi - SAGE Publishing
2001-03-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.1177/14703203010020013301 |
Similar Items
-
Applying Different Techniques to Improve the Bioavailability of Candesartan Cilexetil Antihypertensive Drug
by: Aly UF, et al.
Published: (2020-05-01) -
Biorelevant dissolution of candesartan cilexetil
by: Lucie Gruberová, et al.
Published: (2017-03-01) -
Candesartan cilexetil in cardiovascular prevention
by: A. Ya. Ivleva
Published: (2007-12-01) -
The Safety and Tolerability of Candesartan Cilexetil in CHF
by: Erland Erdmann, et al.
Published: (2000-03-01) -
The safety and tolerability of candesartan cilexetil in CHF
by: Erland Erdmann, et al.
Published: (2000-03-01)